1. Home
  2. MATH vs PRPO Comparison

MATH vs PRPO Comparison

Compare MATH & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

HOLD

Current Price

$0.99

Market Cap

41.9M

Sector

Finance

ML Signal

HOLD

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$25.26

Market Cap

40.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
PRPO
Founded
2015
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
40.1M
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
MATH
PRPO
Price
$0.99
$25.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
59.7K
16.5K
Earning Date
05-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
92.15
EPS
N/A
N/A
Revenue
N/A
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.10
N/A
Revenue Growth
N/A
29.77
52 Week Low
$0.84
$13.02
52 Week High
$4.10
$33.63

Technical Indicators

Market Signals
Indicator
MATH
PRPO
Relative Strength Index (RSI) 47.35 57.63
Support Level $0.87 $22.04
Resistance Level $1.17 $25.27
Average True Range (ATR) 0.07 1.41
MACD -0.01 0.45
Stochastic Oscillator 40.48 79.42

Price Performance

Historical Comparison
MATH
PRPO

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: